Corticosteroids are used for a multitude of indications in palliative patients. In this narrative review, we aim to review literature on the treatment and prevention of neuropsychiatric complications of steroids. For prevention, only lamotrigine had a positive effect in a small number of studies. For treatment, olanzapine appears to be nearly universally effective at low doses, but randomized trial evidence is lacking. Further randomized clinical trials are necessary to elucidate data-driven guidelines for prevention and treatment of corticosteroid-induced neuropsychiatric symptoms. Until further data are available, it is reasonable to consider low dose olanzapine for any patient taking 40 mg of prednisone or its equivalent, especially those with a history of depression or neuropsychiatric symptoms.
RoelandEJBohlkeKBaracosVE, et al.Management of cancer cachexia: ASCO guideline. J Clin Oncol. 2020;38(21):2438–2453.
2.
LoprinziCLKuglerJWSloanJA, et al.Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. J Clin Oncol. 1999;17(10):3299–3306.
3.
HuiDKilgoreKFrisbee-HumeS, et al.Dexamethasone for dyspnea in cancer patients: a pilot double-blind, randomized, controlled trial. J Pain Symptom Manag. 2016;52(1):8–16.e1.
4.
YennurajalingamSFrisbee-HumeSPalmerJL, et al.Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol. 2013;31(25):3076–3082.
5.
YennurajalingamSWilliamsJLChisholmGBrueraE.Effects of dexamethasone and placebo on symptom clusters in advanced cancer patients: a preliminary report. Oncologist. 2016;21(3):384–390.
6.
HaywoodAGoodPKhanS, et al.Corticosteroids for the management of cancer-related pain in adults [published online April 24, 2015]. Cochrane Database Syst Rev. 2015. doi:10.1002/14651858.cd010756.pub2
7.
LavalGGirardierJLassaunièreJMLeducBHaondCSchaererR. The use of steroids in the management of inoperable intestinal obstruction in terminal cancer patients: do they remove the obstruction?Palliat Med. 2000;14(1):3–10.
8.
HardyJLingJMansiJ, et al.Pitfalls in placebo-controlled trials in palliative care: dexamethasone for the palliation of malignant bowel obstruction. Palliat Med. 1998;12(6):437–442.
9.
CurrowDCQuinnSAgarM, et al.Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction. J Pain Symptom Manag. 2015;49(5):814–821.
10.
GeorgeRSundararajJJGovindarajRChackoAGTharyanP. Interventions for the treatment of metastatic extradural spinal cord compression in adults. Cochrane Database Syst Rev. 2015;2015(9):CD006716.
11.
KumarAWeberMHGokaslanZ, et al.Metastatic spinal cord compression and steroid treatment. Clin Spine Surg. 2017;30(4):156–163.
12.
FabregatCAlmendrosSNavarro-MartinAGonzalezJ. Pain flare-effect prophylaxis with corticosteroids on bone radiotherapy treatment: a systematic review. Pain Pract. 2019;20(1):101–109.
13.
WestSKenediC. Strategies to prevent the neuropsychiatric side-effects of corticosteroids. Curr Opin Organ Transplant. 2014;19(2):201–208.
FardetLPetersenINazarethI. Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care. Am J Psychiatr. 2012;169(5):491–497.
16.
BrownESStuardGLigginJDM, et al.Effect of phenytoin on mood and declarative memory during prescription corticosteroid therapy. Biolo Psychiatr. 2005;57(5):543–548.
17.
BrownESFrolABKhanDALarkinGLBretME. Impact of levetiracetam on mood and cognition during prednisone therapy. Eur Psychiatr. 2007;22(7):448–452.
18.
BrownESFrolABobadillaLNejtekVAPerantieDCDhillonH. Effect of lamotrigine on mood and cognition in patients receiving chronic exogenous corticosteroids. Psychosomatics. 2003;44(3):204–208.
19.
BrownESVazquezMNakamuraA.Randomized, placebo-controlled, crossover trial of memantine for cognitive changes with corticosteroid therapy. Biol Psychiatr. 2008;64(8):727–729.
20.
BrownESWolfshohlJShadMUVazquezMOsujiIJ. Attenuation of the effects of corticosteroids on declarative memory with Lamotrigine. Neuropsychopharmacology. 2007;33(10):2376–2383.
21.
BrownESDennistonDGabrielsonBKhanDAKhananiSDesaiS. Randomized, double-blind, placebo-controlled trial of acetaminophen for preventing mood and memory effects of prednisone bursts. Allergy Asthma Proc. 2010;31(4):331–336.
22.
DavisJMLeachAMerkBJanicakPG. Treatment of steroid psychoses. Psychiatr Ann. 1992;22(9):487–491.
23.
GoldmanLSGoveasJ. Olanzapine treatment of corticosteroid-induced mood disorders. Psychosomatics. 2002;43(6):495–497.
24.
BrownESChamberlainWDhananiNParanjpePCarmodyTJSargeantM. An open-label trial of olanzapine for corticosteroid-induced mood symptoms. J Affective Disord. 2004;83(2-3):277–281.
25.
LagomasinoISternT.Steroid psychosis: neuropsychiatric complications of glucocorticoid use. Med Psychiatr. 2001;4(1):35–43.
26.
RossDACetasJS. Steroid psychosis: a review for neurosurgeons. J Neuro-Oncol. 2012;109(3):439–447.
27.
SamalaRVCioconJO. Steroid-induced hallucination following intra-articular administration: a case report and brief review. J Am Med Direct Assoc. 2011;12(8):609–610.
28.
ColeJL.Steroid-induced sleep disturbance and delirium: a focused review for critically ill patients. Fed Pract. 2020;37(6):260–267.
29.
OzbekSInanliI. Secondary mania related to steroid use. Klinik Psikofarmakoloji Bulteni. 2014;24(Supp1):S285.
30.
AtkinTComaiSGobbiG.Drugs for insomnia beyond benzodiazepines: pharmacology, clinical applications, and discovery. Pharmacol Rev. 2018;70(2):197–245.
31.
MontiJMTorteroloPPandi PerumalSR. The effects of second generation antipsychotic drugs on sleep variables in healthy subjects and patients with schizophrenia. Sleep Med Rev. 2017;33:51–57.
32.
DavisMPSangerGJ. The benefits of olanzapine in palliating symptoms. Curr Treat Options Oncol. 2020;22(1):1–20.
33.
NavariRMPywellCMLe-RademacherJG, et al.Olanzapine for the treatment of advanced cancer-related chronic nausea and/or vomiting. JAMA Oncol. 2020;6(6):895.
34.
BeqqalKChauESenouciK, et al.Pemphigus and steroid psychosis: a case report and review of literature. Case Rep Clin Pathol. 2014;1(2):101–104.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
